Teacher Retirement System of Texas Raises Holdings in Alignment Healthcare, Inc. $ALHC

Teacher Retirement System of Texas grew its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 16.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,355 shares of the company’s stock after buying an additional 7,908 shares during the quarter. Teacher Retirement System of Texas’ holdings in Alignment Healthcare were worth $775,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. MCF Advisors LLC boosted its position in shares of Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock worth $40,000 after purchasing an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare in the first quarter valued at about $42,000. Signaturefd LLC boosted its holdings in Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after buying an additional 2,215 shares in the last quarter. Amalgamated Bank grew its position in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after buying an additional 616 shares during the period. Finally, Greenleaf Trust purchased a new position in Alignment Healthcare in the second quarter valued at about $160,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ALHC shares. The Goldman Sachs Group reissued a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a research note on Monday. Barclays lifted their price objective on Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday, October 31st. Zacks Research lowered Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. UBS Group raised their price target on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.85.

Insider Transactions at Alignment Healthcare

In other news, President Dawn Christine Maroney sold 215,662 shares of Alignment Healthcare stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the sale, the president owned 1,797,237 shares of the company’s stock, valued at $29,492,659.17. The trade was a 10.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $16.01, for a total value of $99,999,996.96. Following the transaction, the director owned 24,596,079 shares in the company, valued at $393,783,224.79. This trade represents a 20.25% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 7,427,716 shares of company stock worth $119,650,069 in the last three months. 7.00% of the stock is currently owned by company insiders.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $16.33 on Friday. Alignment Healthcare, Inc. has a 12-month low of $10.18 and a 12-month high of $21.06. The firm has a market cap of $3.27 billion, a price-to-earnings ratio of -136.08 and a beta of 1.17. The company’s 50-day moving average is $16.96 and its two-hundred day moving average is $15.47. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $993.70 million during the quarter, compared to the consensus estimate of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company’s quarterly revenue was up 43.5% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.14) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.